1. Home
  2. FBIZ vs VNDA Comparison

FBIZ vs VNDA Comparison

Compare FBIZ & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Business Financial Services Inc.

FBIZ

First Business Financial Services Inc.

HOLD

Current Price

$52.52

Market Cap

437.9M

Sector

Finance

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

BUY

Current Price

$8.78

Market Cap

474.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
FBIZ
VNDA
Founded
1909
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
437.9M
474.0M
IPO Year
2012
2005

Fundamental Metrics

Financial Performance
Metric
FBIZ
VNDA
Price
$52.52
$8.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$65.00
$14.90
AVG Volume (30 Days)
23.0K
3.6M
Earning Date
04-30-2026
05-13-2026
Dividend Yield
2.58%
N/A
EPS Growth
14.23
N/A
EPS
5.94
N/A
Revenue
N/A
$216,105,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.47
$38.67
P/E Ratio
$8.87
N/A
Revenue Growth
N/A
8.72
52 Week Low
$42.18
$3.81
52 Week High
$60.54
$9.91

Technical Indicators

Market Signals
Indicator
FBIZ
VNDA
Relative Strength Index (RSI) 38.56 56.73
Support Level $46.71 $7.39
Resistance Level $53.17 $9.35
Average True Range (ATR) 1.68 0.55
MACD -0.25 0.09
Stochastic Oscillator 31.57 50.03

Price Performance

Historical Comparison
FBIZ
VNDA

About FBIZ First Business Financial Services Inc.

First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, delivering a full line of commercial banking products, including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically, all the business activity functioned through the region of the United States.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: